Syner-G Pharma Consulting is Consulting Services (B2B) in United States that focus on risk-based chemistry business. Founded in 2007. They cover business area such as operator, a consulting firm, bio-pharmaceutical company, customize science, risk-base chemistry, manufacturing, control, compliance, solution, service, pharmaceutical and biotechnology company, large molecule, cell, gene therapy, product.
2007
( 19 years old in 2026 )
Risk-based Chemistry
-
371 Turnpike Road, 2 Park Central Drive
Suite 110
Southborough, MA 01772
United States
Private
operatora consulting firmbio-pharmaceutical companycustomize sciencerisk-base chemistrymanufacturingcontrolcompliancesolutionservicepharmaceutical and biotechnology companylarge moleculecellgene therapyproduct
* We use standard office opening hours in near Syner-G Pharma Consulting's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Syner-G Pharma Consulting is Consulting Services (B2B) business from United States that founded in 2007 (19 years old in 2026), Syner-G Pharma Consulting business is focusing on Risk-based Chemistry.
Syner-G Pharma Consulting headquarter office and corporate office address is located in 371 Turnpike Road, 2 Park Central Drive Suite 110 Southborough, MA 01772 United States.
Syner-G Pharma Consulting was founded in United States.
In 2026, Syner-G Pharma Consulting is currently focus on risk-based chemistry sector.
Above is snippet of Google Trends for "risk-based chemistry" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Syner-G Pharma Consulting, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
